RA
Rapport Therapeutics, Inc. Common Stock (RAPP)
NASDAQ·Healthcare·Biotechnology
$37.56
-2.55%
Mkt Cap $1.40B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (8 analysts)
$49.00
Range $40.00 – $66.00
Implied Upside
+30.5%
Consensus $49.00 vs current $37.56